Physiological characterization of non-Saccharomyces yeasts from agro-industrial and environmental origins with possible probiotic function

World Journal of Microbiology and Biotechnology

Volumn 25, Issue 4, 2009, Pages 657-666

  Tiago, Fabiana C P ^a   Martins, Flaviano S ^a   Rosa, Carlos A ^a   Nardi, Regina M D ^a   Cara, Denise C ^a   Nicoli, Jacques R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antagonism; Clostridium difficile; Non Saccharomyces yeast; Probiotic

Indexed keywords

BIOASSAY; MICROORGANISMS;

ANIMAL MODELS; ANTAGONISM; CLOSTRIDIUM DIFFICILE; GASTRO-INTESTINAL TRACTS; HEALTH BENEFITS; IN-VITRO; IN-VITRO ASSAYS; IN-VIVO; NON-SACCHAROMYCES YEAST; PROBIOTIC; PROBIOTICS; PROTECTIVE EFFECTS; SACCHAROMYCES;

YEAST;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; MUS; PICHIA; PICHIA KLUYVERI; SACCHAROMYCES;

EID: 61849098347     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-008-9934-9     Document Type: Article

References (50)

1. N Agarwal DN Kamra LC Chaudhary A Sahoo NN Pathak 2000 Selection of Saccharomyces cerevisiae strains for use as a microbial feed additive Lett Appl Microbiol 31 270 273 10.1046/j.1472-765x.2000.00826.x
2. JG Bartlett 1992 Antibiotic-associated diarrhea Clin Infect Dis 15 573 581
3. H Bléhaut J Massot GW Elmer RH Levy 1989 Disposition kinetics of Saccharomyces boulardii in man and rat Biopharm Drug Dispos 10 353 364 10.1002/bdd.2510100403
4. P Born C Lersch B Zimmerhackl M Claassen 1993 The Saccharomyces boulardii therapy of HIV-associated diarrhea Dtsch Med Wochenschr 118 765
5. SJ Booth JL Johnson TD Wilkins 1977 Bacteriocin production by strains of Bacteroides isolated from human faeces and the role of theses strains in the bacterial ecology of the colon Antimicrob Agents Chemother 11 718 724
6. RL Brandão IM Castro EA Bambirra SC Amaral LG Fietto MJM Tropia MJ Neves RG Santos NCM Gomes JR Nicoli 1998 Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae Appl Environ Microbiol 64 564 568
7. S Brugier F Patte 1975 Antagonisme in vitro entre l'ultra-levure et différent germes bactériens Med Paris 45 3 8
8. JP Buts P Bernasconi JP Vaerman C Dive 1990 Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii Dig Dis Sci 35 251 256 10.1007/BF01536771
9. I Castagliuolo MF Riegler L Valenick JT Lamont C Pothoulakis 1999 Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa Infect Immun 67 302 307
10. X Chen EG Kokkotou N Mustafa KR Bhaskar S Sougioultzis M O'Brien C Pothoulakis CP Kelly 2006 Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo, and protects against Clostridium difficile toxin-induced enteritis J Biol Chem 281 24449 24459 10.1074/jbc.M605200200
11. JKS Chia SM Chan H Goldstein 1995 Baker's yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea Clin Infect Dis 20 1581
12. Ciriello CJ, Lachance MA (2001) YEASTCOMPARE. University of Western Ontario, London, ON, Canada
13. D Czerucka I Roux P Rampal 1994 Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells Gastroenterology 106 65 72
14. D Czerucka S Dahan B Mograbi B Rossi P Rampal 2000 Saccharomyces boulardii preserves the barrier function and modulates the transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells Infect Immun 68 5998 6004 10.1128/IAI.68.10.5998-6004.2000
15. D Czerucka P Rampal 2002 Experimental effects of Saccharomyces boulardii on diarrheal pathogens Microbes Infect 4 733 739 10.1016/S1286-4579(02)01592-7
16. S Dahan G Dalmasso V Imbert JF Peyron P Rampal D Czerucka 2003 Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells Infect Immun 71 766 773 10.1128/IAI.71.2.766-773.2003
17. Y Duval-Iflah P Raibaud M Rousseau 1981 Antagonisms among isogenic strains of Escherichia coli in the digestive tracts of gnotobiotic mice Infect Immun 34 957 969
18. L Edwards-Ingram P Gitsham N Burton G Warhurst I Clarke D Hoyle SG Oliver L Stateva 2007 Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae Appl Environ Microbiol 73 2458 2467 10.1128/AEM.02201-06
19. GW Elmer LV McFarland CM Sarawak L Danko RN Greenberg 1999 Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients Aliment Pharmacol Ther 13 1663 1668 10.1046/j.1365-2036.1999.00666.x
20. FAO/WHO (2002) Working Group. Guidelines for the Evaluation of Probiotics in Food, London, ON, Canada, April 30 and May 1
21. JLR Fietto RS Araújo FN Valadão LG Fietto RL Brandão MJ Neves CO Gomes JR Nicoli IM Castro 2004 Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii Can J Microbiol 50 615 621 10.1139/w04-050
22. BR Gedek 1999 Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii Mycoses 42 261 264 10.1046/j.1439-0507.1999.00449.x
23. F Izadnia CT Wong SA Kocoshis 1998 Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat Dig Dis Sci 43 2055 2060 10.1023/A:1018811331596
24. HU Jahn R Ullrich T Schneider RM Liehr HL Schieferdecker H Holst M Zeitz 1996 Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers Digestion 57 95 104
25. JA Katz 2006 Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea J Clin Gastroenterol 40 249 255
26. DJ Kovacs T Berk 2000 Recurrent Clostridium difficile-associated diarrhea and colitis treated with Saccharomyces cerevisiae (baker's yeast) in combination with antibiotic therapy: a case report J Am Board Fam Pract 13 138 140
27. H Kumura Y Tanoue M Tsukahara T Tanaka K Shimazaki 2004 Screening of dairy yeast strains for probiotic applications J Dairy Sci 87 4050 4056
28. Kurtzman CP, Fell JW (1998) The yeasts: a taxonomic study, 4th edn. Elsevier Science Publishers, Amsterdam
29. L Latorre-García L Castillo-Agudo J Polaina 2007 Taxonomical classification of kefir based on the sequence of their ribosomal RNA genes World J Microbiol Biotechnol 23 785 791
30. FS Martins RMD Nardi RME Arantes CA Rosa MJ Neves JR Nicoli 2005 Screening of yeast as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice J Gen Appl Microbiol 51 83 92
31. FS Martins ACP Rodrigues FCP Tiago FJ Penna CA Rosa RME Arantes RMD Nardi MJ Neves JR Nicoli 2007 Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice J Med Microbiol 56 352 359
32. FS Martins IM Castro CA Rosa JR Nicoli MJ Neves 2008 Effect of trehalose on the screening of yeast as probiotic by in vivo and in vitro assays Braz J Microbiol 39 50 55
33. LV McFarland P Bernasconi 1993 Saccharomyces boulardii: a review of an innovative biotherapeutic agent Microb Ecol Health Dis 6 157 171
34. LV McFarland CM Surawicz RN Greenberg GW Elmer KA Moyer SA Melcher KE Bowen JL Cox 1995 Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo Am J Gastroenterol 90 439 448
35. LV McFarland 2006 Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease Am J Gastroenterol 101 812 822
36. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington
37. MJ Neves L Etchebehere RL Brandão IM Castro ME Lima JR Nicoli 2002 Partial characterization of cholera toxin binding on membranes of Saccharomyces boulardii Microecol Ther 29 185 190
38. JR Pleasants 1974
39. C Pothoulakis CP Kelly MA Joshi N Gao CJ O'Keane I Castagliuolo JT Lamont 1993 Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum Gastroenterology 104 1108 1115
40. A Qamar S Aboudola M Warny P Michetti C Pothoulakis JT Lamont CP Kelly 2001 Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice Infect Immun 69 2762 2765
41. F Ramaré JR Nicoli J Dabard T Corring M Ladire AM Gueugneau P Raibaud 1993 Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro Appl Environ Microbiol 59 2876 2883
42. ACP Rodrigues RM Nardi EA Bambirra EC Vieira JR Nicoli 1996 Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice J Appl Bacteriol 81 251 256
43. ACP Rodrigues DC Cara SHGG Fretez FQ Cunha EC Vieira JR Nicoli LQ Vieira 2000 Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice J Appl Microbiol 89 404 414
44. C Scarpignato P Rampal 1995 Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach Chemotherapy 41 48 81
45. D Schellenberg A Bonington M Champion R Lancaster S Webb J Main 1994 Treatment of Clostridium difficile diarrhea with brewer's yeast Lancet 343 171 172
46. CM Surawicz LV McFarland RN Greenberg M Rubin R Fekety ME Mulligan RJ Garcia S Brandmarker K Bowen D Borjal GW Elmer 2000 The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii Clin Infect Dis 31 1012 1017
47. CM Surawicz 2003 Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans Best Pract Res Clin Gastroenterol 17 775 783
48. A Van der Aa Kühle K Skovgaard L Jespersen 2005 In vitro screening of probiotic properties of Saccharomyces cerevisiae var boulardii and food-borne Saccharomyces cerevisiae strains Int J Food Microbiol 101 29 39
49. K Watanabe J Fujimoto M Sasamoto J Dugersuren T Tumursuh S Demberel 2008 Diversity of lactic acid bacteria and yeasts in airag and tarag, traditional fermented milk products of Mongolia World J Microbiol Biotechnol 24 1313 1325
50. D Yarrow 1998